EMPLOYMENT AGREEMENTEmployment Agreement • December 9th, 2011 • Applied Dna Sciences Inc • Industrial organic chemicals • New York
AGREEMENT made as of the 11th day of July, 2011, by and between APPLIED DNA SCIENCES, INC., a Delaware corporation (the “Company”), and KURT H. JENSEN (“Executive”).
ContractConfidentiality Agreement • December 9th, 2011 • Applied Dna Sciences Inc • Industrial organic chemicals • New York
SUBSCRIPTION AGREEMENTSubscription Agreement • December 9th, 2011 • Applied Dna Sciences Inc • Industrial organic chemicals • New York
The undersigned (the “Subscriber”) hereby subscribes for ____________ (___) shares (the “Shares”) of common stock, par value $0.001 per share (“Common Stock”) of Applied DNA Sciences, Inc., a Delaware corporation (the “Company”) at a cash purchase price per share of $0.0475, for an aggregate purchase price of $____________.
JOINT DEVELOPMENT AGREEMENTJoint Development Agreement • December 9th, 2011 • Applied Dna Sciences Inc • Industrial organic chemicals • Pennsylvania
This Joint Development Agreement (the "Agreement") is entered into between C.F. Martin & Co., Inc., a Pennsylvania Corporation having a business address of 510 Sycamore Street, Nazareth, PA 18064 ("Martin"), and Applied DNA Sciences, a Delaware Corporation having a business address of 25 Health Sciences Drive, Suite 215, Stony Brook, NY 11790 ("ADNAS")(Martin and ADNAS are collectively referred to as the "Parties"), on June 30, 2011 (the "Effective Date").
APPLIED DNA SCIENCES, INC. PURCHASE WARRANTSecurity Agreement • December 9th, 2011 • Applied Dna Sciences Inc • Industrial organic chemicals • New York
THIS PURCHASE WARRANT certifies that, for value received, __________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to the close of business on July 15, 2018 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), at the Exercise Price (as defined below) an aggregate of __________ fully paid, validly issued and nonassessable shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company. As used herein “Underlying Securities” means, the shares of Common Stock, issuable upon exercise of this Warrant.
